<DOC>
	<DOCNO>NCT00147147</DOCNO>
	<brief_summary>To evaluate survival benefit adjuvant chemotherapy curative resection D2 great lymph node dissection T3-4 gastric cancer patient .</brief_summary>
	<brief_title>Randomized Trial Adjuvant Chemotherapy With Cisplatin Followed UFT Serosa-positive Gastric Cancer ( JCOG9206-2 )</brief_title>
	<detailed_description>Purpose : To evaluate survival benefit adjuvant chemotherapy curative resection serosa-positive gastric cancer patient , multicenter phase III clinical trial conduct 13 participate center Japan . Methods : From January 1993 March 1998 , 268 patient randomize either adjuvant chemotherapy ( 135 pt ) surgery alone ( 133 pt ) . The chemotherapy comprise intraperitoneal cisplatin 70 mg/m2 closing abdomen , surgery intravenous cisplatin 70 mg/m2 ( day 14 ) 5-fluorouracil ( 5-FU ) 700 mg/m2 daily ( day 14-16 ) , oral FU ( UFT ) 267 mg/m2 daily 4 week surgery next 12 month . The primary endpoint overall survival . Relapse-free survival site recurrence secondary endpoint . Comparison : gastrectomy D2 great lymph node dissection versus gastrectomy adjuvant chemotherapy curative resection serosa-positive gastric cancer patient .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1 . Curative operation D2 great lymph node dissection 2 . Histologically proven gastric adenocarcinoma 3 . Macroscopically serosapositive ( T34 ) 4 . No metastasis level 3 4 lymph node station ( N02 ) 5 . 75 year younger 6 . Negative peritoneal lavage cytology 7 . Adequate organ function WBC &gt; =4000/mm3 , Hb &gt; =11.0g/dl , Plt &gt; =100.000/mm3 , AST/ALT , T.Bil , BUN , Creatinine &lt; =2.5 x Normal Upper Limit , Creatinine clearance &lt; =70 ml/min 8 . Written inform consent 1 . Prior chemotherapy radiotherapy 2 . Synchronous metachronous malignancy organ</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>gastric neoplasm</keyword>
	<keyword>gastrectomy</keyword>
	<keyword>adjuvant chemotherapy</keyword>
	<keyword>randomize trial</keyword>
	<keyword>T3 T4 carcinoma stomach/Gastric Neoplasm</keyword>
</DOC>